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Abstract
Recent results showed that certain DEAD box protein RNA helicases, DDX3 and DDX1, play an
important role in the HIV infection cycle by facilitating the export of long, singly spliced or unspliced
HIV RNAs from the nucleus via the CRM1-Rev pathway. Close examination of an extensive
microarray expression profiling dataset obtained from cells latently infected with HIV induced to
undergo lytic viral replication indicated that additional DEAD box proteins, beyond DDX3 and
DDX1, exhibit differential expression during lytic HIV replication, and in latently infected cells prior
to induction into active replication. This finding provides additional evidence that the involvement
of DEAD box proteins and other RNA-binding proteins may play roles in active HIV replication
and in the control of viral latency. Agents targeting these functions may offer new approaches to
antiretroviral therapy and the therapeutic manipulation of HIV latency.
Findings
The DEAD box proteins, a family of RNA helicases con-
taining the conserved amino acid motif Asp-Glu-Ala-Asp
(D-E-A-D in the single letter amino acid code), play an
essential role in many aspects of cellular RNA metabolism
(reviewed in [1,2]), including RNA transport, transcrip-
tion, spliceosome function, ribosome assembly, the initi-
ation of translation, and RNA degradation. The HIV Rev
protein regulates a key aspect of the HIV replication cycle
by mediating the switch between the early pattern of HIV
gene expression, in which short, multiply spliced mes-
sages encoding the viral regulatory genes Tat, Rev, and Nef
are exported from the nucleus, and the late pattern of viral
gene expression in which larger singly spliced and
unspliced messages that encode the viral structural pro-
teins and that constitute the RNA genomes of progeny vir-
ions are exported from the nucleus [3-5]. Recent work,
reviewed in reference [6], from the Jeang [7] and Pomer-
antz [8] laboratories implicate the DDX3 and DDX1
DEAD box proteins as additional critical co-factors for the
Rev-mediated export of the long HIV singly spliced and
unspliced mRNAs.
In a directed analysis of a large data set, which describes
global changes in cellular gene patterns before and after a
latently infected cell line was induced into active viral rep-
lication [9], we found that genes encoding many DEAD
box proteins, and other RNA and DNA binding and mod-
ification proteins, in addition to DDX3 and DDX1,
showed differential regulation, suggesting that HIV repli-
cation may be associated with generalized changes in the
expression of many DEAD box proteins and other RNA
binding proteins.
Yedavalli et al. [7] identified DDX3 in a differential dis-
play-based screen for cellular messages upregulated in the
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nuclear export protein CRM1, which is essential for
nuclear export mediated by the HIV Rev protein [10,11],
shuttles between the cytoplasm and nucleus, facilitates
the nuclear export of RRE-containing RNA in the presence
of Rev, and advances HIV replication. Fang et al. [8] iden-
tified DDX1 in a two hybrid screen as a Rev- and RRE-
binding protein that enhanced HIV replication, improved
the expression of RRE-containing RNA, and modified the
subcellular distribution of Rev from a predominantly
nuclear to a predominantly cytoplasmic distribution.
Our work on large scale expression profiling in HIV
actively and latently infected cells has been guided by the
hypothesis that there is one set of cellular conditions
which is ideal for normal cellular growth and homeosta-
sis, that there is another set of conditions which may be
better suited to supporting viral replication, and that HIV
has evolved ways of altering the host cell so as to better
support viral replication. An interesting corollary of the
hypothesis is that targeting the products of the differen-
tially expressed genes may inhibit viral replication by
making the host cell environment less hospitable to viral
replication (reviewed in [12,13]). Several laboratories
have conducted large scale expression profiling studies
investigating changes in cellular gene expression during
HIV replication [14-16], and have, in some cases, identi-
fied new potential targets for antiviral therapy. The obser-
vations that altering the intracellular environment by, for
example, targeting kinases involved in signal transduction
and cell cycle regulation inhibits HIV replication lends
additional support for this hypothesis [17,18]. Investiga-
tors studying other viruses, for example Kaposi's sarcoma-
associated herpesvirus, have also noted changes in host
cell gene expression patterns that accompany infection
and transformation [19,20], and have identified targets
for potential therapeutic intervention based on those
studies. In examining our data, we therefore try to note
interesting and potentially targetable host cell genes that
show alterations in expression during HIV replication and
latency. In our earlier study, we identified cellular genes
encoding proteins that constituted new targets for agents
aimed at activating latently infected cells into active viral
replication [9]. In our initial examination of our dataset,
among the several classes of genes showing discrete, tem-
porally-dependent changes in expression during lytic rep-
lication, we noticed that several DDX genes and genes
encoding other factors involved in RNA metabolism were
differentially expressed. However, prior to the work by
Yedavalli et al. and Fang et al., we had no clear sense of
how the differential expression of those genes might con-
tribute to facilitating HIV replication. Those recent studies
prompted us to undertake a more detailed analysis of our
data.
In our study, we compared RNA samples obtained from
HIV latently infected cell lines prior to induction of active
replication by the integrated HIV-1 provirus and follow-
ing such induction with phorbol myristyl acetate (PMA).
We profiled ACH-2 cells treated with PMA side by side
with similarly treated HIV-1 naïve parental A3.01 cells to
assess differential cellular gene expression patterns associ-
ated with HIV lytic replication. The dataset was generated
from samples obtained from three independent biologi-
cal replicate experiments and at least two microarray
hybridizations were done for each time point from each
biological replicate (for a minimum of 6 microarrays per
time point). A detailed description of the cell culture,
induction, RNA isolation, and microarray labeling and
hybridization methods are contained in reference [9]. Fol-
lowing microarray data acquisition, data were analyzed
using commercial (GenePix Pro software, Axon Instru-
ments) and in-house software (microarray database sys-
tem (mAdb), hosted by Center for Information
Technology, NIH). Using BRB -ArrayTools http://
linus.nci.nih.gov/BRB-ArrayTools, the data were subjected
to statistical analyses using univariate parametric and
multivariate permutation analyses, based on the one sam-
ple random variance t-statistic, where significance was
based on P < 0.001 and the proportion of false discoveries
was limited to 0.10 with a 90% confidence level. 1740
genes showed differential gene expression at a minimum
of one timepoint during lytic replication. Hierarchical
clustering analyses were performed using mAdb clustering
tools, as well as Treeview http://rana.lbl.gov/EisenSoft
ware.htm. Since the data was obtained from latently
infected cell lines, there may be some concern that
infected primary cells may behave in a somewhat different
fashion. However, the advantages of using latently
infected cell lines are significant: Activation into active
replication is reasonably synchronous and includes essen-
tially all the cells, so that the signal from the cells support-
ing active replication is not diluted by the signal from
uninfected cells or cells with virus at different stages of
viral replication. Also, the signal comes only from infected
cell and not from cells responding to effects from the
exposure to very large numbers of defective viral particles
that are in high multiplicity of infection inocula.
Figure 1 shows the expression patterns for genes encoding
DEAD box proteins, and other genes encoding RNA heli-
cases and RNA binding proteins, as assigned by the gene
ontology database http://www.geneontology.org[21]. We
found that a number of DEAD-box proteins were signifi-
cantly up regulated (P < 0.001) immediately following
induction (0.5 hr post induction p.i). These included
DDX10, a DEAD box protein with expression in many tis-
sues having tumorigenic activity when fused to the nucle-
oporin NUP98 [22,23], DDX21, a DEAD-box protein
originally identified as a nucleolar protein thought to bePage 2 of 5
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A compilation of the expression profiles of genes with known or putative involvement in RNA binding, transport or splicing 
before and after latently infected ACH-2 cells were induced into active replication. Panel A shows selected genes involved in 
RNA metabolism that were differentially expressed during active replication in the infected cells (ACH-2 cells) at 0.5–8 hr 
post-induction (p.i.) compared to similarly induced, parental uninfected A3.01 cells. Panel B shows gene expression profiles of 
a subset of DEAD-box proteins, following induction into active replication, of the genes displayed in panel A. Only genes that 
passed the criteria for statistical significance (P < 0.001) for the 0.5–8 hr p.i. time period (but not for other time periods) are 
shown. Panel C shows the expression profiles of genes encoding DDX18 and DDX39, which were up regulated during viral 
latency and during latency and early lytic replication. Panel D shows the expression profile of genes encoding ABC transporter 
proteins. The bottom of the figure shows a scale indicating the color values corresponding to the expression ratio in HIV 
infected/HIV uninfected cells for the differential expression of each gene shown in the figure at the different time points. Panel 
E is a graphical representation of the expression patterns observed in the selected DEAD-box proteins showing fold change in 
gene expression over corresponding controls.Page 3 of 5
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DEAD box protein first identified in U5 SnRNPs with sig-
nificant homology to the yeast Prp28p splicing factor[25],
and DDX52, a human DEAD box protein identified
through its homologies to a yeast gene [26].
Other genes encoding proteins with RNA splicing/binding
and RNA transport activity were also up regulated during
this period, including the methylated mRNA cap binding
proteins EIF4G1 [27] and NCBP1 (CBP80) [28], which
function in translation initiation and may also be
involved in mediating nuclear export of RNA. In addition,
genes encoding other proteins involved in nucleic acid-
protein interactions were also upregulated, such as mem-
bers of the SWI/SNF family of ATP-dependent chromatin
remodeling factors involved in cell cycle control and the
regulation of gene expression, SMARCA2 and SMARCA5
[29,30]. Another class of genes that shows differential
expression during the early time period (0.5–8 hr p.i.) are
the genes encoding the ATP-dependent ABC transporter
proteins, which share sequence homology with members
of the helicase family at the ATP binding site [31], indicat-
ing that many ATP-dependent processes may be targeted
by early viral replication steps, not only as a means to
facilitate viral RNA transport but also as a mechanism to
shut off or divert cellular functions requiring ATP
hydrolysis.
Our findings that several DEAD box protein genes are
upregulated during HIV replication lend support to the
published finding that two cellular DEAD-box proteins,
including one (DDX3) that was identified in a broad-
based screen for differentially expressed genes [7], may be
important mediators for Rev-mediated RNA export. Our
data also show that several other RNA binding proteins
are differentially regulated during HIV-1 replication, sug-
gesting that there may be a general involvement of these
classes of genes in the HIV replication cycle, that the
involvement is not limited only to DDX3 and DDX1. The
additional DEAD box family members and other proteins
involved in RNA metabolism may be interesting candi-
dates for further mechanistic studies on HIV replication.
For example, EIF4G1 has been shown to interact with
CBP80 (NCBP1) [32], as well as with EIF4A [33], an RNA
helicase with a DEAD-box motif in its sequence. The bind-
ing of EIF4G1 to EIF4A is essential for the proper function
of EIF4A as an RNA helicase [34]. In our study, genes
encoding EIF4G1 and CBP80 were differentially expressed
during early lytic replication. Further study of the interac-
tions of EIF4G1, CBP80 and EIF4A1 may thus be impor-
tant in elucidating Rev function and viral RNA export, as
well as the synthesis of viral proteins. While some of the
differentially expressed DEAD box proteins, beyond
DDX1 and DDX3, may play a part in Rev-dependent viral
RNA export from the nucleus, it is also possible that the
broad induction of the expression of DEAD box protein-
encoding genes and genes encoding other RNA binding
factors may indicate that such gene products are involved
in other aspects of HIV replication. These aspects of HIV
replication could involve activities in which the DEAD
box proteins have already been implicated, such as tran-
scription, spliceosome assembly, and translation.
In our recent publication [9], we showed that several host
cell genes were differentially expressed in latently infected
cell lines, even before induction of the integrated virus
into active replication. In an approach analogous to our
hypotheses concerning the involvement of cellular genes
in active viral replication, we showed that targeting the
products of some cellular genes differentially expressed in
the latently infected cells could activate viral replication,
ejecting the virus from latency. In our examination of the
DEAD box proteins, we noted that two genes encoding
DEAD box proteins, DDX18, a DEAD-box protein
induced by Myc and Max [35] and DDX39, (or URH49),
a DEAD-box protein induced by growth stimulation or
protein synthesis inhibition thought to be involved in
splicing and nuclear export, with homology to the yeast
Sub2p protein [36], were differentially expressed during
viral latency (DDX39, DDX18) and at early times
(DDX18) after induction into active replication. Since
some DEAD box proteins are important for viral RNA
nuclear export and active viral replication, it may be rea-
sonable to consider that other members of this family
could have natural inhibitory activity for HIV replication,
such as that seen with mutated DDX3 proteins [7].
Accordingly, certain DEAD box proteins may have roles in
maintaining HIV latency. If this reasoning is correct, then
the selective targeting of such DEAD box factors might
offer another means of ending HIV latency and for deplet-
ing latent HIV reservoirs. The DEAD box proteins and
other RNA helicases may therefore represent important
cellular factors that can be manipulated to alter viral rep-
lication in several therapeutically useful ways.
Cellular genes may be differentially expressed during viral
replication for many different reasons. Differential expres-
sion of cellular genes may conceivably occur because of
viral actions on the host cell designed to optimize the cell
for viral replication, because of cellular responses to infec-
tion aimed at inhibiting viral infection, or may be funda-
mentally unrelated to key aspects of viral replication.
However, the findings that several DEAD box protein
genes are differentially expressed during HIV replication,
together with the recently published observations that
two DEAD box genes, DDX3 and DDX1, exhibit differen-
tial expression during HIV replication and have important
functions in HIV replication lend additional credence to
the hypothesis that a careful, large scale study of differen-
tially expressed cellular genes can provide insights intoPage 4 of 5
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genesis. Future studies may reveal additional human co-
factors for HIV replication. These cellular co-factors many
represent important new therapeutic targets.
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